Pharmaceuticals | Top 5 Selected Papers in 2022–2023 in the Section “Pharmacology”
2 April 2024
- “Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer”
by Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, Takashi Fujimoto, Kaishi Otsuka, Masami Niwa and Keisuke Tsutsumi
Pharmaceuticals 2022, 15(2), 151; https://doi.org/10.3390/ph15020151
Available online: https://www.mdpi.com/1424-8247/15/2/151
- “Metabolic Action of Metformin”
by Izabela Szymczak-Pajor, Sylwia Wenclewska and Agnieszka Śliwińska
Pharmaceuticals 2022, 15(7), 810; https://doi.org/10.3390/ph15070810
Available online: https://www.mdpi.com/1424-8247/15/7/810
- “Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment”
by Lu Turković, Luka Bočkor, Oscar Ekpenyong, Tajana Silovski, Mila Lovrić, Slaven Crnković, Biljana Nigović and Miranda Sertić
Pharmaceuticals 2022, 15(5), 614; https://doi.org/10.3390/ph15050614
Available online: https://www.mdpi.com/1424-8247/15/5/614
- “Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics”
by Valentina Tateo, Paola Valeria Marchese, Veronica Mollica, Francesco Massari, Razelle Kurzrock and Jacob J. Adashek
Pharmaceuticals 2023, 16(4), 614; https://doi.org/10.3390/ph16040614
Available online: https://www.mdpi.com/1424-8247/16/4/614
- “The Kynurenine Pathway in Healthy Subjects and Subjects with Obesity, Depression and Chronic Obstructive Pulmonary Disease”
by Per G. Farup, Håvard Hamarsland, Knut Sindre Mølmen, Stian Ellefsen and Knut Hestad
Pharmaceuticals 2023, 16(3), 351; https://doi.org/10.3390/ph16030351
Available online: https://www.mdpi.com/1424-8247/16/3/351